Effect of a Prebiotic on Colic and Crying and Fussing Behaviour in Infants (CRI)

August 22, 2019 updated by: John Cairney, McMaster University

Effect of Prebiotic on Colic and Crying and Fussing Behaviour in Infants CRI Study: Colic Relief Initiative Study

Colic, or inconsolable crying and fussing, affects around 20% of babies who are 3 months of age or younger. To date, there are no known treatments that have been found to help reduce colic and its symptoms in babies. The investigators would like to see whether a baby formula that contains a prebiotic will lead to the same improvements in babies with colic. The investigators will test this by giving some babies a formula with the prebiotic and other babies a placebo formula.

Study Overview

Status

Terminated

Conditions

Study Type

Interventional

Enrollment (Actual)

1

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ontario
      • Hamilton, Ontario, Canada, L8P 1H6
        • David Braley Health Sciences Centre

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

2 weeks to 1 month (CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Healthy, term infant from a singleton birth (=>37 weeks gestational age); formula fed; primary caregiver able to read and write in English; current colicky behaviour

Exclusion Criteria:

  • Infants with known genetic syndromes; birth weight (<2500g); use of proton pump inhibitors; use of antibiotics in previous week; use of nutritional colic remedies; use of probiotics; maternal medical history of diabetes (excluding gestational diabetes), tuberculosis, or any perinatal infection while pregnant with child enrolled in study; presence of blood in infant stool sample; possible cow milk protein allergy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: QUADRUPLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Experimental Infant Formula
Milk-based infant formula with prebiotics
Ready-to-feed infant formula to be fed ad libitum
Placebo Comparator: Reference group
Milk-based infant formula without prebiotics
Ready-to-feed infant formula to be fed ad libitum

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Infant crying and fussing behaviour
Time Frame: 6 weeks
As assessed by the Barr Baby Behavior Diary
6 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Infant crying and fussing behaviour
Time Frame: 6 weeks
As assessed by actigraphy and accelerometry
6 weeks
Stool Microbiota
Time Frame: 6 weeks
6 weeks
Stool calprotectin
Time Frame: 6 weeks
6 weeks
Parent satisfaction
Time Frame: 6 weeks
As assessed by parent survey
6 weeks
Infant behaviour
Time Frame: 6 weeks
As assessed by parent survey
6 weeks
Infant feeding patterns
Time Frame: 6 weeks
As assessed by parent survey
6 weeks
Infant stool patterns
Time Frame: 6 weeks
As assessed by parent survey
6 weeks
Postnatal depression
Time Frame: 6 weeks
As assessed by parent survey
6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 13, 2017

Primary Completion (Actual)

August 15, 2019

Study Completion (Actual)

August 15, 2019

Study Registration Dates

First Submitted

October 23, 2015

First Submitted That Met QC Criteria

October 23, 2015

First Posted (Estimate)

October 26, 2015

Study Record Updates

Last Update Posted (Actual)

August 28, 2019

Last Update Submitted That Met QC Criteria

August 22, 2019

Last Verified

August 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • INCH-681

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Colic

Clinical Trials on Experimental Infant formula

3
Subscribe